Quel est le prix pour Dongwha Pharm.Co.,Ltd (000020)

Le prix pour Dongwha Pharm.Co.,Ltd (000020) est $3.52

Quelle est la capitalisation boursière pour Dongwha Pharm.Co.,Ltd (000020)

La capitalisation boursière pour Dongwha Pharm.Co.,Ltd (000020) est $97.56M

Revenus de Dongwha Pharm.Co.,Ltd (000020)

Dongwha Pharm Co., Ltd. is a South Korean entity primarily engaged in the production and distribution of pharmaceutical goods. The company's diverse offerings include prescription-only medications addressing a wide spectrum of health concerns such as digestive and infectious diseases, cardiovascular and metabolic disorders, inflammatory and respiratory conditions, musculoskeletal and neurological ailments, as well as dermatological and urological issues. Furthermore, they market an extensive selection of over-the-counter (OTC) remedies, covering categories like digestive aids, cold and flu treatments, anti-inflammatory and respiratory solutions, skin care, oral hygiene, liver support, nutritional supplements, tonics, topical pain relief, antihistamines, and remedies for sore throats, among other products. Beyond pharmaceuticals, Dongwha Pharm also ventures into quasi-drugs, health supplements, food and beverage items, and cosmetics. Established in 1897, the firm maintains its headquarters in Seoul, South Korea.

Année	Revenus	Changez
Pas assez de données pour les dates fournies.

Année

Revenus

Changez

Pas assez de données pour les dates fournies.

Entreprise	Revenus	Différence de revenus	Pays
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$6.61B	-	IN

Entreprise

Revenus

Différence de revenus

Pays